NCT07743164
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
Not specified
Clinical trial condition
Ovarian Neoplasms
Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.
2,301 public trials
509 recruiting studies
Ovarian Neoplasms trial results
Not Yet Recruiting
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
NCT07752875
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +56 more
- Locations
-
Not specified
Not Yet Recruiting
Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]
NCT07694427
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
NCT07747506
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Centre Leon Berard Lyon, France
- Institut Curie Paris, France
Not Yet Recruiting
A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）
NCT07690332
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
Not specified
Not Yet Recruiting
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery
NCT07724106
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Not Yet Recruiting
Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab
NCT07720180
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States
NCT07716800
- Conditions
- Adnexal Diseases, Cognition Disorders, Cognitive Decline, +25 more
- Locations
-
Not specified
Not Yet Recruiting
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
NCT07714668
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
Not specified